Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amjevita
Pharma
FDA approves Amgen's interchangeable biosimilar of J&J's Stelara
The FDA has approved Amgen’s biosimilar version of J&J's Stelara. But the new product will not launch until 2025 because of a prior settlement.
Kevin Dunleavy
Nov 1, 2023 10:20am
Boehringer rolls out unbranded Humira biosim at steep discount
Oct 4, 2023 10:53am
Biosimilars make inroads into Humira sales; docs still cautious
Sep 19, 2023 9:35am
Amgen's hyped Humira biosimilar generates just $19M in Q2 sales
Aug 4, 2023 8:35am
Amgen launched Humira biosim to its own detriment
Apr 28, 2023 11:05am
Doctors are still hesitant to trust biosimilars, survey says
Feb 16, 2023 1:50pm
